In advanced maternal age, decisions between donor and autologous oocytes should be based on what?

• A. Donor oocytes often yield higher live birth rates in advanced age; decisions individualized
• B. Always use donor oocytes for age over 42
• C. Autologous oocytes are always preferred
• D. Donor oocytes are rarely considered

Answer: (A)

In advanced maternal age, the choice between donor and autologous oocytes hinges on prognosis and patient values. Oocyte quality declines with age, which lowers implantation and live birth rates with autologous eggs and increases the risk of aneuploidy. Using donor oocytes from younger, healthier eggs can substantially improve live birth prospects because the eggs have better quality and lower chromosomal risk. Yet there isn’t a one-size-fits-all rule: the decision is individualized, taking into account the patient’s ovarian reserve, prior ART outcomes, medical history, genetic considerations, and personal, ethical, and financial factors.

Donor eggs are not automatically required for a certain age, and autologous eggs are not always preferred. Donor eggs aren’t rarely considered in practice; they’re a common option when prognosis with autologous eggs is limited and the patient or couple prefers a higher chance of success with fewer chromosomal risks.